Oscotec Inc.的更多文章
-
Oscotec @ EHA2023
The results from our phase 2 study of cevidoplenib in immune thrombocytopenia (ITP) were presented during a…
-
Oscotec R&D Day (2023.03.06)
Click to watch on YouTube!!
-
Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib
February 24, 2023 : Oscotec Inc. announced topline results for Phase 2 trial evaluating the efficacy, safety and…
北京印刷学院学生
10 个月Is OAAS-4/OAAS-24/OAAS-48 available? What's the current offer? How can I contact you? Is there an email address? Thank you!